Your A-Z of episodes

Emma Banks, CEO at ramarketing, joined the podcast and spoke on how, despite market headwinds, the pharma services sector is looking up.

Rani Powers, Founder & CEO of Pluto Bio, shares how her passion for coding and biology led to Pluto, a platform accelerating drug discovery.

Tamar Thompson Head of Global Corporate Affairs at Alexion, AstraZeneca Rare Disease, joins the podcast to discuss the value and impact being acquired by AstraZeneca had on Alexion

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chris Garabedian, CEO at Xontogeny and Venture Fund Manager at Perceptive Advisors. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chris, covering: Chris Garabedian founded Xontogeny in June of 2016 to …

Kent Payne, CEO at Aliri discusses the value of scientists engaging with clients to build relationships and showcase technical expertise.

Gil Roth, PBOA President, joins the podcast to discuss the latest pharma and biopharma industry news, plus green shoots to watch out for.

Steven Chevillotte joins Molecule to Market to discuss the key elements that have played a role in the continued success of SaniSure.

Join Raman Sehgal for a quick update on the life sciences sector’s current state amid market challenges and where to find him on the road.

Yussuf Goolam, Co-Founder, President and CEO of RxSource, recently spoke about his incredible journey into the clinical trials space.

Kevin Cook, CEO at Sterling Pharma Solutions spoke on his key tips to mastering M&A and growing exponentially in the North American market.